Program:
Human blood and plasma contain many proteins, the extraction and
purification of which are of great medical and economic importance.
Transmission of infectious diseases via blood transfusion and the use of
processed blood plasma and components have placed a high priority on the
development of new strategies for enhancing the safety of the blood supply.
Screening blood for the detection of infectious agents is continuing to
advance but still does not provide complete safety. To further complicate
the issue, cost-effectiveness and the threat of emerging and/or crossover
infective agents must also be considered. Recent advances and new
strategies for the inactivation and removal of infectious agents in whole
blood, component concentrates, and plasma are the focal point of CHI's
Fourth Annual Blood Safety & Screening conference.
Registration :
Cambridge Healthtech Institute
1037 Chestnut Street, Newton Upper Falls, MA 02164
Tel: 617-630-1300 Fax: 617-630-1325
E-Mail: chi@healthtech.com
Deadline for Abstracts: Jan. 9, 1998
Email for Requests and Registration: chi@healthtech.com